Announcements
- Teleflex Announces First Quarter 2024 Earnings Conference Call Information
- Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
- Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
- Teleflex Announces Quarterly Dividend
- Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
- Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
- Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
- Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
- Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 47.10m |
Free float | 46.98m |
P/E (TTM) | 27.42 |
Market cap | 9.76bn USD |
EPS (TTM) | 7.56 USD |
Annual div (ADY) | 1.20 CHF |
---|---|
Annual div yield (ADY) | -- |
Div ex-date | Feb 29 2024 |
Div pay-date | Mar 15 2024 |
Data delayed at least 15 minutes.
More ▼